Cholesterol‐lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis
Renée E. Poupon, Khadija Ouguerram, Yves Chrétien, Claudine Verneau, Eveline Eschwège, Thierry Magot, Raoul Poupon – 1 April 1993 – We have previously shown in a 2‐yr controlled trial that hypercholesterolemia, frequent in primary biliary cirrhosis, is lowered by ursodeoxycholic acid (13 to 15 mg daily). To further investigate this effect, we analyzed the influence of long‐term ursodeoxycholic acid administration on serum lipids, lipoproteins and bile acids.